newsfilter
← Latest News
GlobeNewswire·

Kuehn Law Encourages Investors of Amicus Therapeutics, Inc. to Contact Law Firm

NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amicus Therapeutics, Inc. (NASDAQ:FOLD) breached their